Teladoc Health, Inc. (TDOC) › Cash & EquivalentsTeladoc Health, Inc. (TDOC) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2012: $8.69M2013: $3.21M2014: $46.44M2015: $55.07M2016: $50.02M2017: $42.82M2018: $423.99M2019: $514.35M2020: $733.32M2021: $893.48M2022: $918.18M2023: $1.12B2024: $1.30B2025: $781.08M$781.08M2012Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$781.08M-39.8%2024$1.30B+15.5%2023$1.12B+22.4%2022$918.18M+2.8%2021$893.48M+21.8%2020$733.32M+42.6%2019$514.35M+21.3%2018$423.99M+890.2%2017$42.82M-14.4%2016$50.02M-9.2%2015$55.07M+18.6%2014$46.44M+1345.7%2013$3.21M-63.1%2012$8.69M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share